Search

Your search keyword '"Maly, R."' showing total 76 results

Search Constraints

Start Over You searched for: Author "Maly, R." Remove constraint Author: "Maly, R." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
76 results on '"Maly, R."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

14. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

15. PB0473 VTE Outcomes in Patients Treated with Direct Oral Anticoagulants and Concurrent Antiepileptic Drugs: Data from the START2 and the RIETE

16. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

17. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

18. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

19. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

20. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

21. DVT Management and Outcome Trends, 2001 to 2014

22. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

23. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

24. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

25. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

26. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

27. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

28. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

29. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

30. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

31. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

32. Predictors of active cancer thromboembolic outcomes

34. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

35. Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

36. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

37. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

38. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort

39. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

40. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

41. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database

42. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

43. Venous thromboembolism in young adults: Findings from the RIETE registry

44. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

45. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

46. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

47. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

48. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

50. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

Catalog

Books, media, physical & digital resources